Article
Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs.
Expert opinion on drug metabolism & toxicology - 1 Aug 2018
Skubic Cene, Drakulić Živa, Rozman Damjana
Abstract excerpt
INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is the most frequent liver disease in the world. It describes a term for a group of hepatic diseases including steatosis, fibrosis, and cirrhosis that can finally lead to hepatocellular carcinoma. There are many factors influencing NAFLD initiation and progression, such as obesity, dyslipidemia, insulin resistance, genetic factors, and hormonal changes....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
